U.S. flag

An official website of the United States government

NM_003907.3(EIF2B5):c.943C>T (p.Arg315Cys) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 17, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002535429.5

Allele description [Variation Report for NM_003907.3(EIF2B5):c.943C>T (p.Arg315Cys)]

NM_003907.3(EIF2B5):c.943C>T (p.Arg315Cys)

Gene:
EIF2B5:eukaryotic translation initiation factor 2B subunit epsilon [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q27.1
Genomic location:
Preferred name:
NM_003907.3(EIF2B5):c.943C>T (p.Arg315Cys)
HGVS:
  • NC_000003.12:g.184140517C>T
  • NG_015826.1:g.10496C>T
  • NM_003907.3:c.943C>TMANE SELECT
  • NP_003898.2:p.Arg315Cys
  • LRG_1278t1:c.943C>T
  • LRG_1278:g.10496C>T
  • LRG_1278p1:p.Arg315Cys
  • NC_000003.11:g.183858305C>T
  • NM_003907.2:c.943C>T
Protein change:
R315C
Links:
dbSNP: rs113994063
NCBI 1000 Genomes Browser:
rs113994063
Molecular consequence:
  • NM_003907.3:c.943C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003525681Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 17, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The effect of genotype on the natural history of eIF2B-related leukodystrophies.

Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, Kaneski CR, Pineda M, Troncoso M, Uziel G, Surtees R, Pugin D, Chaunu MP, Rodriguez D, Boespflug-Tanguy O.

Neurology. 2004 May 11;62(9):1509-17.

PubMed [citation]
PMID:
15136673

Functional analysis of recently identified mutations in eukaryotic translation initiation factor 2Bɛ (eIF2Bɛ) identified in Chinese patients with vanishing white matter disease.

Leng X, Wu Y, Wang X, Pan Y, Wang J, Li J, Du L, Dai L, Wu X, Proud CG, Jiang Y.

J Hum Genet. 2011 Apr;56(4):300-5. doi: 10.1038/jhg.2011.9. Epub 2011 Feb 10.

PubMed [citation]
PMID:
21307862
See all PubMed Citations (7)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003525681.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 315 of the EIF2B5 protein (p.Arg315Cys). This variant is present in population databases (rs113994063, gnomAD 0.01%). This missense change has been observed in individuals with leukoencephalopathy with vanishing white matter (PMID: 15136673, 21307862, 25089094, 30755392). ClinVar contains an entry for this variant (Variation ID: 598970). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt EIF2B5 protein function with a negative predictive value of 80%. This variant disrupts the p.Arg315 amino acid residue in EIF2B5. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11704758, 17646634; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024